CFIHX | TIBRX | CFIHX / TIBRX | |
Total Expense Ratio | 0.27 | 1.54 | 18% |
Annual Report Gross Expense Ratio | 0.27 | 1.72 | 16% |
Fund Existence | 9 years | 21 years | - |
Gain YTD | 14.784 | 25.064 | 59% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 118B | 17.3B | 682% |
Annual Yield % from dividends | 3.30 | 3.50 | 94% |
Returns for 1 year | 12.92 | 25.35 | 51% |
Returns for 3 years | 30.84 | 62.06 | 50% |
Returns for 5 years | 50.17 | 93.52 | 54% |
Returns for 10 years | N/A | 108.12 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBC | 22.95 | 0.38 | +1.68% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
EWQ | 43.89 | 0.39 | +0.90% |
iShares MSCI France ETF | |||
PBJN | 28.97 | 0.18 | +0.62% |
PGIM S&P 500 Buffer 20 ETF - Jun | |||
GLU | 17.84 | 0.05 | +0.28% |
Gabelli Utility & Income Trust (The) | |||
SLQD | 50.62 | 0.01 | +0.02% |
iShares 0-5 Year Invmt Grade Corp Bd ETF |